BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 33021328)

  • 1. [Should all patients with traumatic brain injury receive tranexamic acid?].
    Rostami E; Kongstad P; Marklund N
    Lakartidningen; 2020 Oct; 117():. PubMed ID: 33021328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of tranexamic acid on intracranial haemorrhage and infarction in patients with traumatic brain injury: a pre-planned substudy in a sample of CRASH-3 trial patients.
    Mahmood A; Needham K; Shakur-Still H; Harris T; Jamaluddin SF; Davies D; Belli A; Mohamed FL; Leech C; Lotfi HM; Moss P; Lecky F; Hopkins P; Wong D; Boyle A; Wilson M; Darwent M; Roberts I
    Emerg Med J; 2021 Apr; 38(4):270-278. PubMed ID: 33262252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial.
    CRASH-3 trial collaborators
    Lancet; 2019 Nov; 394(10210):1713-1723. PubMed ID: 31623894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A nested mechanistic sub-study into the effect of tranexamic acid versus placebo on intracranial haemorrhage and cerebral ischaemia in isolated traumatic brain injury: study protocol for a randomised controlled trial (CRASH-3 Trial Intracranial Bleeding Mechanistic Sub-Study [CRASH-3 IBMS]).
    Mahmood A; Roberts I; Shakur H
    Trials; 2017 Jul; 18(1):330. PubMed ID: 28716153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Out-of-Hospital Tranexamic Acid vs Placebo on 6-Month Functional Neurologic Outcomes in Patients With Moderate or Severe Traumatic Brain Injury.
    Rowell SE; Meier EN; McKnight B; Kannas D; May S; Sheehan K; Bulger EM; Idris AH; Christenson J; Morrison LJ; Frascone RJ; Bosarge PL; Colella MR; Johannigman J; Cotton BA; Callum J; McMullan J; Dries DJ; Tibbs B; Richmond NJ; Weisfeldt ML; Tallon JM; Garrett JS; Zielinski MD; Aufderheide TP; Gandhi RR; Schlamp R; Robinson BRH; Jui J; Klein L; Rizoli S; Gamber M; Fleming M; Hwang J; Vincent LE; Williams C; Hendrickson A; Simonson R; Klotz P; Sopko G; Witham W; Ferrara M; Schreiber MA
    JAMA; 2020 Sep; 324(10):961-974. PubMed ID: 32897344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding the neuroprotective effect of tranexamic acid: an exploratory analysis of the CRASH-3 randomised trial.
    Brenner A; Belli A; Chaudhri R; Coats T; Frimley L; Jamaluddin SF; Jooma R; Mansukhani R; Sandercock P; Shakur-Still H; Shokunbi T; Roberts I;
    Crit Care; 2020 Nov; 24(1):560. PubMed ID: 33172504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tranexamic acid for patients with traumatic brain injury: a randomized, double-blinded, placebo-controlled trial.
    Yutthakasemsunt S; Kittiwatanagul W; Piyavechvirat P; Thinkamrop B; Phuenpathom N; Lumbiganon P
    BMC Emerg Med; 2013 Nov; 13():20. PubMed ID: 24267513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRASH-2 (Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage) intracranial bleeding study: the effect of tranexamic acid in traumatic brain injury--a nested randomised, placebo-controlled trial.
    Perel P; Al-Shahi Salman R; Kawahara T; Morris Z; Prieto-Merino D; Roberts I; Sandercock P; Shakur H; Wardlaw J
    Health Technol Assess; 2012; 16(13):iii-xii, 1-54. PubMed ID: 22417901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tranexamic acid in traumatic brain injury: an explanatory study nested within the CRASH-3 trial.
    CRASH-3 Intracranial Bleeding Mechanistic Study Collaborators
    Eur J Trauma Emerg Surg; 2021 Feb; 47(1):261-268. PubMed ID: 32076783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benefits of the tranexamic acid in head trauma with no extracranial bleeding: a prospective follow-up of 180 patients.
    Chakroun-Walha O; Samet A; Jerbi M; Nasri A; Talbi A; Kanoun H; Souissi B; Chtara K; Bouaziz M; Ksibi H; Rekik N
    Eur J Trauma Emerg Surg; 2019 Aug; 45(4):719-726. PubMed ID: 29922895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Tranexamic Acid on Prevention of Hemorrhagic Mass Growth in Patients with Traumatic Brain Injury.
    Fakharian E; Abedzadeh-Kalahroudi M; Atoof F
    World Neurosurg; 2018 Jan; 109():e748-e753. PubMed ID: 29074420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antifibrinolytics in the treatment of traumatic brain injury.
    Schober P; Loer SA; Schwarte LA
    Curr Opin Anaesthesiol; 2022 Oct; 35(5):583-592. PubMed ID: 35900731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tranexamic acid in patients with traumatic brain injury: a meta-analysis.
    Sarhan RM; Boshra MS; Abdelrahim MEA; Osama H
    Rev Esp Anestesiol Reanim (Engl Ed); 2024 May; 71(5):360-367. PubMed ID: 38387502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tranexamic acid and traumatic brain injuries.
    Sanford K; Garcia S
    JAAPA; 2020 Dec; 33(12):53-54. PubMed ID: 33234898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tranexamic acid for acute gastrointestinal bleeding (the HALT-IT trial): statistical analysis plan for an international, randomised, double-blind, placebo-controlled trial.
    Brenner A; Afolabi A; Ahmad SM; Arribas M; Chaudhri R; Coats T; Cuzick J; Gilmore I; Hawkey C; Jairath V; Javaid K; Kayani A; Mutti M; Nadeem MA; Shakur-Still H; Stanworth S; Veitch A; Roberts I;
    Trials; 2019 Jul; 20(1):467. PubMed ID: 31362765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRASH-3 - tranexamic acid for the treatment of significant traumatic brain injury: study protocol for an international randomized, double-blind, placebo-controlled trial.
    Dewan Y; Komolafe EO; Mejía-Mantilla JH; Perel P; Roberts I; Shakur H;
    Trials; 2012 Jun; 13():87. PubMed ID: 22721545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of tranexamic acid in intracranial haemorrhage: A meta-analysis.
    Xiong Y; Guo X; Huang X; Kang X; Zhou J; Chen C; Pan Z; Wang L; Goldbrunner R; Stavrinou L; Stavrinou P; Lin S; Chen Y; Hu W; Zheng F
    PLoS One; 2023; 18(3):e0282726. PubMed ID: 37000863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prehospital Tranexamic Acid (TXA) in Patients with Traumatic Brain Injury (TBI).
    Maegele M
    Transfus Med Rev; 2021 Oct; 35(4):87-90. PubMed ID: 34598876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tranexamic acid is not inferior to placebo with respect to adverse events in suspected traumatic brain injury patients not in shock with a normal head computed tomography scan: A retrospective study of a randomized trial.
    Harmer JW; Dewey EN; Meier EN; Rowell SE; Schreiber MA
    J Trauma Acute Care Surg; 2022 Jul; 93(1):98-105. PubMed ID: 35358154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of tranexamic acid in acute traumatic brain injury: A meta-analysis of randomized controlled trials.
    Zhang M; Liu T
    Am J Emerg Med; 2024 Jun; 80():35-43. PubMed ID: 38502985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.